Clinical Trials Directory

Trials / Unknown

UnknownNCT02759497

Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

One of the most common and serious complications in decompensated cirrhotic patients (DCPs) is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial peritonitis (SBP), which account for 40% 70% of cases, followed by urinary tract infections, pneumonia and cellulitis. Serum amyloid A (SAA) and C-reactive protein (CRP) are acute-phase proteins predominantly produced and secreted by hepatocytes. Other cells including lymphocytes, monocytes, and macrophages can also produce these proteins. The induction of SAA and CRP synthesis is triggered by a number of cytokines, chiefly IL-6, which is released from a variety of cell types, but mainly from macrophages and monocytes at inflammatory sites

Detailed description

Increased serum CRP and SAA levels have been found in a number of disorders, including bacterial infections, malignancies tissue injuries and tissue rejection. Therefore, new studies of early diagnosis, prevention and treatment are needed to improve clinical outcomes.

Conditions

Interventions

TypeNameDescription
OTHERserum amyloid A levelserum amyloid A level (SAA)

Timeline

Start date
2016-03-01
Primary completion
2020-10-01
Completion
2020-11-01
First posted
2016-05-03
Last updated
2017-06-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02759497. Inclusion in this directory is not an endorsement.